To access this element change to forms mode OFF
Grant Award View - GA171114
Pharmacy–based screening and quality use of medicines in kidney disease
GA ID:
GA171114
Agency:
Department of Health and Aged Care
Approval Date:
20-May-2021
Publish Date:
11-Jun-2021
Category:
Medical Research
Grant Term:
10-Jun-2021 to 6-Dec-2025
Value (AUD):
$1,894,075.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Pharmacy–based screening and quality use of medicines in kidney disease
Purpose:
Chronic Kidney Disease (CKD) is a growing public health concern with over 1.7 million Australians unaware that they have indicators of CKD. Community pharmacists in Australia are a largely untapped health resource for the identification and management of patients with CKD.
The overall goal is to screen people for CKD via community pharmacies and provide a quality use of medicines service which includes identifying medications that are potentially inappropriate (as per the kidney function) and/or nephrotoxic and provide recommendations to optimise use of medications. The benefits include reduced medication–related harm; improved public knowledge and awareness of CKD risk factors; and expanded public health roles for community pharmacists.
GO ID:
GO Title:
MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity
Internal Reference ID:
MRFQI000008
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
UNIVERSITY OF SYDNEY
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
CAMPERDOWN
Town/City:
Camperdown
Postcode:
2006
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
2006
Country:
AUSTRALIA